Drug Shortage Report for APO-DEFERASIROX
Report ID | 238844 |
Drug Identification Number | 02461552 |
Brand name | APO-DEFERASIROX |
Common or Proper name | DEFERASIROX |
Company Name | APOTEX INC |
Market Status | MARKETED |
Active Ingredient(s) | DEFERASIROX |
Strength(s) | 250MG |
Dosage form(s) | TABLET FOR SUSPENSION |
Route of administration | ORAL ORAL |
Packaging size | 30 BLS |
ATC code | V03AC |
ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-09-24 |
Estimated end date | 2024-12-20 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-11-29 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 150 SIGNET DRIVE TORONTO, ONTARIO CANADA M9L 1T9 |
Company contact information | Apotex Customer Service - 1-877-427-6839 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2024-11-29 | French | Compare |
v7 | 2024-11-29 | English | Compare |
v6 | 2024-10-10 | French | Compare |
v5 | 2024-10-10 | English | Compare |
v4 | 2024-10-04 | French | Compare |
v3 | 2024-10-04 | English | Compare |
v2 | 2024-09-27 | French | Compare |
v1 | 2024-09-27 | English | Compare |
Showing 1 to 8 of 8